Introduction of Dr. Maria Lapteva from University of Geneva Meet Dr. Maria Lapteva, senior scientist at Prof. Kalia’s lab in the Pharmaceutical School of the University of Geneva. She will talk about nanoparticles in skin delivery for the hybrid workshop on 6 April about Quality and Equivalence of topical formulations

I’m Stefan Mühlebach, Prof. em. in Pharmacology and Hospital Pharmacy at the University of Basel in Switzerland. Due to my activity in nanopharmaceutical and regulatory science, I was a founding member of the Non-Biological Complex Drugs working party in the Netherland more the 10 years ago.

My name is Richard Guy.  I am Professor of Pharmaceutical Science at the University of Bath in the UK.  Since 2013, my research has been funded by the FDA’s Office of Generic Drugs to develop and validate methods to assess the bioequivalence of topical drug products.

Dr. Vinod Shah, one of the hybrid workshop speakers about the Quality and Equivalence of Topical Products and Nanotechnology Challenges, is introducing his talk. This event will be held on 6 April 2021 in Geneva.

Let’s get prepared ! Here are some snapshots  of the preparation of the workshop  (EMA newly coming guideline on Quality and Equivalence of Topical Products and Nanotechnology Challenges-6 April 2021) with some of the speakers and the moderator.

Teledyne Hanson is a global technology company based in Southern California that invents, engineers, and manufactures dissolution and diffusion test instruments that set the standard for the entire industry. We take great pride in the fact that our research and equipment help ensure the world’s pharmaceuticals and cosmetics are pure,